Literature DB >> 23790340

Effect of Chinese herbal compound on liver fibrosis in rabbits with schistosomiasis by B-ultrasound.

Xiao-Lu Liang1, Jia-Ying Yuan.   

Abstract

OBJECTIVE: To explore the value of B-ultrasound on the evaluation of the effects of traditional Chinese medicine compound of Radix astragali, Salvia miltiorrhiza and Angelica sinensis, and TCM + praziquantel on liver fibrosis in rabbits with schistosomiasis.
METHODS: The hepatic fibrosis model in rabbits with schistosomiasis was established. The experimental animals (24 rabbits) were randomly divided into four groups (group A, B, C and D, n=6). Group A (control group) was only treated by praziquantel; Group B was treated by mixture of Radix astragali and Salvia miltiorrhiza + praziquantel; Group C was treated by mixture of Radix astragali and Angelica sinensis + praziquantel; Group D was treated by mixture of Radix astragali, Salvia miltiorrhiza and Angelica sinensis + praziquantel. Then B-ultrasonogram was used to evaluate the effects.
RESULTS: Each group showed certain curative effect on liver fibrosis in rabbits with schistosomiasis. The efficacy of group B, C and D was better than group A, and that of group D was the best. The differences in long diameter, thickness diameter, transverse diameter and portal vein inner diameter of liver before and after treatment were statistically significant (P<0.05). The liver function indexes and liver fibrosis indexes were significantly improved after treatment (P<0.05).
CONCLUSIONS: The mixture of Radix astragali, Salvia miltiorrhiza and Angelica sinensis combined with Western medicine treatment can obviously improve the efficacy on liver fibrosis of schistosomiasis.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790340     DOI: 10.1016/S1995-7645(13)60114-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  7 in total

Review 1.  Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.

Authors:  Jing-Si Wang; Qiu-Yun Zhang; Jin-Lian Cheng; Lan-Yu Chen; Nai-Li Yao; Gui-Zhi Sun; Yu-Ling Chu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

2.  Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats.

Authors:  Weijuan Huang; Lin Li; Xiaopeng Tian; Jinjin Yan; Xinzheng Yang; Xinlong Wang; Guozhen Liao; Genquan Qiu
Journal:  Mol Med Rep       Date:  2014-11-05       Impact factor: 2.952

3.  24-Week Exposure to Oxidized Tyrosine Induces Hepatic Fibrosis Involving Activation of the MAPK/TGF-β1 Signaling Pathway in Sprague-Dawley Rats Model.

Authors:  Zhuqing Leslie Li; Yonghui Shi; Guowei Le; Yinyi Ding; Qi Zhao
Journal:  Oxid Med Cell Longev       Date:  2015-12-14       Impact factor: 6.543

4.  Effects of Dangguibuxue decoction on rat glomerular mesangial cells cultured under high glucose conditions.

Authors:  Xiao-Dan Ren; Ying-Wen Zhang; Xiu-Ping Wang; Ya-Rong Li
Journal:  BMC Complement Altern Med       Date:  2017-05-25       Impact factor: 3.659

Review 5.  Evaluation of the Pharmaceutical Properties and Value of Astragali Radix.

Authors:  Amy G W Gong; Ran Duan; Huai Y Wang; Xiang P Kong; Tina T X Dong; Karl W K Tsim; Kelvin Chan
Journal:  Medicines (Basel)       Date:  2018-05-21

6.  Integrating Network Pharmacology and Experimental Validation to Investigate the Effects and Mechanism of Astragalus Flavonoids Against Hepatic Fibrosis.

Authors:  Lin An; Yuefang Lin; Leyan Li; Muyan Kong; Yanmei Lou; Jinjun Wu; Zhongqiu Liu
Journal:  Front Pharmacol       Date:  2021-01-22       Impact factor: 5.810

Review 7.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.